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Synthesis
2-hydroxyisobutrylysine (1):  2-hydroxyisobutryic acid (3.35g, 32mmol) and N-
hydroxysuccinimide (3.75g, 32.6mmol) were combined in 30 mL of CH3CN.  After stirring for 10 
minutes, N,N'-dicyclohexylcarbodiimide (DCC) (6.72g, 32.6mmol) was added and allowed to 
stir. After three hours the solution was filtered and the solvent removed to give 2-
hydroxyisobutyryl-OSu (S1) as a yellowish oil (3.24g, 50%), that was used directly without 
further purification. Separately, L-lysine monohydrochloride (980 mg, 5.37mmol) was added to 
5mL of saturated aqueous NaHCO3.  The mixture was stirred at room temperature for ten 
minutes and CuSO4 (669mg, 2.68mmol) added. 2-hydroxyisobutyryl-OSu (S1) from the first step 
(3.24g) was re-suspended in 10 mL of acetone, and added drop-wise to the lysine complex over 
four hours to produce a blue slurry. The reaction was quenched with methanol and evaporated 
to dryness.  The solid was re-suspended in water (50mL) and stirred at room temperature. To 
the stirring solution was added 8-quinolinol (1.95g, 13.43mmol) and stirred vigorously overnight 
to produce a green slurry.  The green slurry was filtered, and the filtrate washed with ethyl 
acetate (3 x 30mL).  The aqueous layer was then evaporated to dryness to give 1 (967mg, 
77%).  Rf=0.36 (3:1:1, 1-butanol:acetic acid:water, pink with ninhydrin stain) 1H NMR (300 MHz, 
D2O):   1.19, (8H, m),1.35, (2H, m), 1.68, (2H, m), 3.01 (2H, t, J = 6Hz), 3.60 (1H, t, J = 6Hz), 
13C NMR (75 MHz, D2O): 21.6, 25.2, 26.3, 28.1, 29.9, 38.6, 54.3, 73.0, 176.3, 179.1. MS-
ESI (m/z) [M+H]+, calc C10H21N2O4   233.1501, found 233.1492.
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Synthetase screening
Chemically competent E. coli DH10-B were doubly-transformed with pBK_sfGFP151TAG and 
each of four different synthetase plasmids (pBK_MmPylS, pBK_EV16-5, pBK_EV17, 
pBK_EV20). A single colony from each plate was picked to inoculate 4mL liquid culture.  Once 
the liquid cultures became saturated, they were streaked on three different plates: plate 1 (LB, 
Kan 50g/mL, Tet 15g/mL, 0.2% arabinose), plate 2 (LB, Kan 50g/mL, Tet 15g/mL, 0.2% 
arabinose, 2mM Nε-Boc-lysine) and plate 3 (LB, Kan 50g/mL, Tet 15g/mL, 0.2% arabinose, 
1mM 2-hydroxyisobutyryl lysine) (Figure S2).
Protein expression and mass spectrometry
From the 4mL culture containing the pBK_MmPylS synthetase plasmid, 1mL was used to 
inoculate an expression cultures in 200mL of LB media containing tetracycline and kanamycin.  
After the culture reached an OD600=0.6, arabinose (final percentage of 0.2%) and 5mM 
hydroxyisobutyryl lysine (1). A negative control culture was treated the same, with no unnatural 
amino acid added. The cultures were incubated overnight and then the cells pelleted at 6,000 x 
g, and resuspended in 10mL of lysis buffer (50mM NaH2PO4, 300mM NaCl, 10mM imidazole, 
pH=8) with 5mg of lysozyme.  After 30 minutes each culture was sonicated 3 x 1 minute at 50% 
power with a 30 second rest.  The resulting pellets were centrifuged at 15,000 x g and the lysate 
transferred to a clean 15mL Falcon tube.  500l of Promega His Bind was added to each tube 
and shaken for 30 minutes.  The resin was pelleted by a centrifugation and sequentially washed 
3 times with 12mL of lysis/binding buffer.  The resin was eluted with 500μl elution buffer (50mM 
Figure S2.  Screening for unnatural amino acid incorporation in sfGFP using four 
different PylS variants.  MmPylS was streaked three times.  Plates were 
photographed on a UV transilluminator.
NaH2PO4, 300mM NaCl, 250mM imidazole, pH=8). Samples for analysis by SDS-PAGE were 
20L. Tryptic peptide MS was performed as described using an Agilent 6340 ion trap.1 Intact 
protein MS was performed by direct infusion into an Agilent 6340 ion trap, and the resulting 
spectrum deconvoluted using MagTran software. 
Sequence of sfGFP protein. Site of mutation (Y151) shown as X:
MGGSHHHHHHGMASMMSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATNGKLTLKFICTTGKLPV 
PWPTLVTTLTYGVQCFSRYPDHMKRHDFFKSAMPEGYVQERTISFKDDGTYKTRAEVKFEGDTLVNRIEL 
KGIDFKEDGNILGHKLEYNFNSHNVXITADKQKNGIKANFKIRHNVEDGSVQLADHYQQNTPIGDGPVLL 
PDNHYLSTQSVLSKDPNEKRDHMVLLEFVTAAGITHGMDELYK
Figure S3. A) Intact protein ESI-MS of sfGFP containing 1 or 2. Calculated masses correspond to 
the protein sequence minus the N-terminal methionine (131) and GFP chromophore maturation 
(20). Calculated mass difference between 1 and 2 is 14, observed mass difference is 14. Minor 
peaks seen in ESI data correspond to phosphate adducts2 (M+98), and is seen for both 1 and 2.
sfGFP containing 2
Calculated (minus Met) = 28329
Observed = 28325
sfGFP containing 1
Calculated (minus Met) = 28315
Observed = 28311
1H NMR of 1:
13C NMR of 1: 
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